RHB analyst Jarick Seet has maintained his “buy” call on Venture Corp with an unchanged target price of $22.60, as the company has continued its recovery trajectory, which is in line with the brokerage’s estimates.
“Management expects to deliver a stronger 2HFY2020 vs 1HFY2020 – provided COVID-19-induced lockdowns and disruptions do not deteriorate further. The group is currently fulfilling its backlog of existing orders while its research & development (R&D) labs have plans to subsequently release a number of newly developed products into manufacturing early 2021,” says Seet in a report dated Dec 22.
